COMPARING BRENTUXIMAB VEDOTIN OVERALL SURVIVAL DATA TO STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA (HL) POST-AUTOLOGOUS STEM CELL TRANSPLANT (ASCT)

被引：0
|
作者：
Woods, B. [1 ]
Thompson, J. [1 ]
Barcena, L. [1 ]
Liu, Y. [2 ]
Huang, H. [2 ]
Martinez, C. [3 ]
机构：
[1] Oxford Outcomes, Oxford, England
[2] Millennium Pharmaceut Inc, Cambridge, MA USA
[3] Inst Hematol & Oncol, Barcelona, Spain
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1728
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A509 / A509
页数：1
相关论文
共 50 条
  • [21] Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma
    Damlaj, Moussab
    Alaskar, Ahmed
    Alahmari, Bader
    Ghazi, Samer
    Hejazi, Ayman
    Alzahrani, Mohsen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S233 - S233
  • [22] Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphoma
    Herrera, A. F.
    Palmer, J.
    Martin, P.
    Armenian, S.
    Tsai, N-C
    Kennedy, N.
    Sahebi, F.
    Cao, T.
    Budde, L. E.
    Mei, M.
    Siddiqi, T.
    Popplewell, L.
    Rosen, S. T.
    Kwak, L. W.
    Nademanee, A.
    Forman, S. J.
    Chen, R.
    ANNALS OF ONCOLOGY, 2018, 29 (03) : 724 - 730
  • [23] THE COST-EFFECTIVENESS OF NIVOLUMAB FOR THE TREATMENT OF PEOPLE WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT AND BRENTUXIMAB VEDOTIN
    Jones, B.
    Ward, T.
    Harrison, J. P.
    Hurst, M.
    Tyas, D.
    McEwan, P.
    Gordon, J.
    VALUE IN HEALTH, 2017, 20 (09) : A433 - A433
  • [24] Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma
    Illidge, Tim
    Bouabdallah, Reda
    Chen, Robert
    Gopal, Ajay K.
    Moskowitz, Craig H.
    Ramchandren, Radhakrishnan
    Shustov, Andrei R.
    Tilly, Herve
    Trippett, Tanya M.
    Gibb, Adam
    Grove, Laurie E.
    Advani, Ranjana
    LEUKEMIA & LYMPHOMA, 2015, 56 (03) : 703 - 710
  • [25] Outcomes of Pediatric Relapsed/Refractory Hodgkin Lymphoma Post Autologous Stem Cell Transplant
    Sarangarajan, Sanjana
    Singh, Shivani Deep
    Gupta, Aditya Kumar
    Meena, Jagdish Prasad
    Seth, Rachna
    INDIAN JOURNAL OF PEDIATRICS, 2025, 92 (03): : 308 - 308
  • [26] Efficacy of Reduced-Intensity Allogeneic Stem Cell Transplant after Brentuximab Vedotin in Patients with Hodgkin Lymphoma Relapsed after Autologous Transplant
    Zallio, Francesco
    Busca, Alessandro
    Mordini, Nicola
    Fornaro, Maria Jose
    Bruno, Benedetto
    Catania, Gioacchino
    Salvi, Flavia
    Parvis, Guido
    Ladetto, Marco
    Pini, Massimo
    BLOOD, 2014, 124 (21)
  • [27] Brentuximab Vedotin in Transplant-Naive Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients
    Zinzani, Pier Luigi
    Pellegrini, Cinzia
    Cantonetti, Maria
    Re, Alessandro
    Pinto, Antonello
    Pavone, Vincenzo
    Rigacci, Luigi
    Celli, Melania
    Broccoli, Alessandro
    Argnani, Lisa
    Pulsoni, Alessandro
    ONCOLOGIST, 2015, 20 (12): : 1413 - 1416
  • [28] THE IMPACT OF TREATMENT WITH BRENTUXIMAB VEDOTIN ON OVERALL SURVIVAL OF PATIENTS WITH HODGKIN LYMPHOMA RELAPSED AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION. A NATIONWIDE POPULATION BASED ANALYSIS
    Tsirigotis, P.
    Vassilakopoulos, T.
    Mpatsis, I.
    Kaloyiannidis, P.
    Bousiou, Z.
    Gkirkas, K.
    Sakellari, I.
    Roussou, P.
    Pangalis, G.
    Moschoyianni, M.
    Vassilopoulos, G.
    Repoussis, P.
    Megalakaki, E.
    Michalis, E.
    Anagnostopoulos, N.
    Calpadaki, C.
    Papadaki, H.
    Margaritis, D.
    Kotsianidis, I.
    Hatzimichael, E.
    Briasoulis, E.
    Spyridonidis, A.
    Grentzelias, D.
    Mpanti, A.
    Anargyrou, K.
    Poulakidas, E.
    Giannoullia, P.
    Gribabi, D.
    Apostolidis, I.
    Stamouli, M.
    Konstantopoulos, K.
    Karakasis, D.
    Pappa, V.
    Panayiotidis, P.
    Harhalakis, N.
    Anagnostopoulos, A.
    Angelopoulou, M.
    HAEMATOLOGICA, 2017, 102 : 84 - 84
  • [29] Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era - real-world data from Hungary
    Husi, Kata
    Szabo, Roxana
    Pinczes, Laszlo Imre
    Foldeak, Dora
    Dudley, Reka
    Szomor, Arpad
    Koller, Beata
    Gopcsa, Laszlo
    Illes, Arpad
    Miltenyi, Zsofia
    ANNALS OF HEMATOLOGY, 2023, 102 (09) : 2555 - 2563
  • [30] Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary
    Kata Husi
    Roxána Szabó
    László Imre Pinczés
    Dóra Földeák
    Réka Dudley
    Árpád Szomor
    Beáta Koller
    László Gopcsa
    Árpád Illés
    Zsófia Miltényi
    Annals of Hematology, 2023, 102 : 2555 - 2563
12345